The 81st Annual Meeting of the Japanese Society of Hematology

Session information

Oral Session

Oral Session 3-15D AML: Novel Therapy

Sun. Oct 13, 2019 3:40 PM - 4:40 PM No.15 (Tokyo International Forum, 7F G701)

Chair: Koichi Takahashi (The University of Texas MD Anderson Cancer Center)

Noriko Fukuhara1, Ilseung Choi2, Kensuke Usuki3, Takahiro Yamauchi4, Jalaja Potluri5, Paulo Maciag5, Wan-Jen Hong6, Hideyuki Honda7, Ahmed Salem5, Shuichi Taniguchi8 (1.Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Miyagi, Japan, 2.Department of Hematology, National Hospital Organization, Kyushu Cancer Center, Fukuoka, Fukuoka, Japan, 3.Department of Hematology, NTT Medical Center Tokyo, Tokyo, Tokyo, Japan, 4.Department of Hematology and Oncology, University of Fukui Hospital, Fukui, Fukui, Japan, 5.AbbVie, Inc., North Chicago, IL, United States of America, 6.Genentech, Inc., South San Francisco, CA, United States of America, 7.AbbVie GK, Tokyo, Tokyo, Japan, 8.Department of Hematology, Toranomon Hospital, Tokyo, Tokyo, Japan)

Eunice S. Wang1, Andrew Lane3, Kendra Sweet4, Marina Konopleva2, Shay Shemesh5, Ivan Bergstein5, Christopher Brooks5, Naveen Pemmaraju2 (1.Chief, Leukemia Service Professor of Oncology, Dept Medicine Director, Hematologic Procurement Shared Resource Department of Tumor Immunology Roswell Park Comprehensive Cancer Institute, Buffalo, NY, United States of America, 2.The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America, 3.Dana-Farber Cancer Institute, Boston, MA, United States of America, 4.H. Lee Moffitt Cancer Center, Tampa, FL, United States of America, 5.Stemline Therapeutics, Inc, New York, NY, United States of America)

Naoki Takezako1, Masaki Yamaguchi2, Toru Kiguchi3, Shuichi Miyawaki4, Yuji Heike5, Koichi Masui6, Nami Tagami7, Tomoki Naoe8 (1.Dept. of Hematology, NHO Disaster Medical Center, Tokyo, Japan, 2.Dept. of Hematology, Ishikawa Prefectural Central Hospital, Ishikawa, Japan, 3.Dept. of Hematology, Chugoku Central Hospital, Fukuyama, Japan, 4.Dept. of Hematology, Tokyo Metropolitan Ohtsuka Hospital, Tokyo, Japan, 5.Immunotherapy and Cell Therapy, St. Luke's International Hospital, Tokyo, Japan, 6.Clinical Management, Otsuka Pharmaceutical Co., Ltd, Tokyo, Japan, 7.Medical Affairs, Otsuka Pharmaceutical Co., Ltd, Tokyo, Japan, 8.National Hospital Organization Nagoya Medical Center, Nagoya, Japan)

Adolfo de la Fuente1,29, Mar Tormo2, Paola Beneit3, Cristina Gil4, Teresa Bernal Castillo5, Josefina Serrano Lopez6, Karla Javier Gonzalez7, Antonia Sampol Mayol8, Julio Davila Valls9, Carmen Martinez Chamorro10, Sandra Suarez Ordonez11, Celina Benavente12, Juan Bergua13, Santiago Jimenez Bravo de la Laguna14, Ana Espadana15, Pilar Martinez Sanchez16, Maria Luz Amigo17, Maria Jose Sayas LLoris18, Pilar Herrera19, Blanca Boluda20,29, Rosa Fernandez21, Salut Brunet22, Itziar Oiartzabal23, Ana Munoz Gama24, Montserrat Arnan Sangerman25, Antonio Diaz Lopez20, Susana Vives Polo26, Rosa Coll Jorda27, Angela Figuera28, Pau Montesinos20,29 (1.Hematology, MD Anderson CC Madrid, Madrid, Madrid, Spain, 2.H. Clinico Universitario de Valencia, Valencia, Valencia, Spain, 3.H. San Juan, Alicante, Alicante, Spain, 4.H. General de Alicante, Alicante, Alicante, Spain, 5.H. Central de Asturias, Oviedo, Oviedo, Spain, 6.H. Reina Sofia, Cordoba, Cordoba, Spain, 7.H. General Universitario de Valencia, Valencia, Valencia, Spain, 8.H. Son Espases, Palma de Mallorca, Baleares, Spain, 9.Complejo Asistencial de Avila, Avila, Castilla y Leon, Spain, 10.H. Quiron Salud, Madrid, Madrid, Spain, 11.H. Alvaro Cunqueiro, Vigo, Pontevedra, Spain, 12.H. Clinico San Carlos, Madrid, Madrid, Spain, 13.H. San Pedro de Alcantara, Caceres, Caceres, Spain, 14.H. Doctor Negrin, Las Palmas de Gran Canaria, Las Palmas, Spain, 15.H. Coimbra EPE Coimbra, Coimbra, Coimbra, Portuguese Republic, 16.H. 12 de Octubre, Madrid, Madrid, Spain, 17.H. Morales Meseguer, Murcia, Murcia, Spain, 18.H. Doctor Peset, Valencia, Valencia, Spain, 19.H. Ramon y Cajal, Madrid, Madrid, Spain, 20.U. Medicina Traslacional MD Anderson CC Madrid, Valencia, Valencia, Spain, 21.H. Insular Las Palmas, Las Palmas e Gran Canaria, Las Palmas, Spain, 22.H. Sant Pau, Barcelona, Barcelona, Spain, 23.H. Universitario Araba, Vitoria, Alava, Spain, 24.H. Virgen de la Salud, Toledo, Toledo, Spain, 25.ICO Duran i Reynals, Barcelona, Barcelona, Spain, 26.ICO H. Germans Trias i Pujol, Badalona, Barcelona, Spain, 27.ICO Girona, Girona, Girona, Spain, 28.H. La Princesa, Madrid, Madrid, Spain, 29.H. La Fe de Valencia, Valencia, Valencia, Spain)